The great pharmacare debate: An ‘overly simplistic’ solution or needed system rationalization?
Universal pharmacare is an “overly simplistic” solution that risks cutting access to drugs, says a senior executive at one of Canada’s largest pharmaceutical companies. “It…
- By: Michael McKiernan
- January 10, 2018 September 13, 2019
- 13:00